DOVLATOVA, N., WIJEYERATNE, Y.D., FOX, S.C., MANOLOPOULOS, P., JOHNSON, A.J., WHITE, A.E., LATIF, L., RALEVIC, V. and HEPTINSTALL, S., 2009. Detection of P2Y14 receptor protein on platelets and investigation of the role of P2Y14 in platelet function. J Thromb Haemostas. Supplement 2, WE-045
HEPTINSTALL, STAN, ESPINOSA, DAVID IYU, MANOLOPOULOS, PANAGIOTIS, GLENN, JACKIE R, WHITE, ANN E, JOHNSON, ANDREW, DOVLATOVA, NATALIA, FOX, SUE C, MAY, JANE A, HERMANN, DAVID, MAGNUSSON, OLAFUR and STEFAN, 2008. DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease. Platelets. 19(8), 605-13
DOVLATOVA, NATALIA, WIJEYERATNE, YANUSHI D, FOX, SUSAN C, MANOLOPOULOS, PANAGIOTIS, JOHNSON, ANDREW J, WHITE, ANN E, LATIF, M LIAQUE, RALEVIC, VERA and HEPTINSTALL, STANLEY, 2008. Detection of P2Y(14) protein in platelets and investigation of the role of P2Y(14) in platelet function in comparison with the EP(3) receptor. Thrombosis and Haemostasis. 100(2), 261-70 MANOLOPOULOS, P., GLENN, J.R., FOX, S.C., MAY, J.A., DOVLATOVA, N.L., TANG, S.W., THOMAS, N.R., RALEVIC, V. and HEPTINSTALL, S., 2008. Acyl derivatives of coenzyme A inhibit platelet function via antagonism at P2Y(1) and P2Y(12) receptors: A new finding that may influence the design of anti-thrombotic agents Platelets. 19(2), 134-145 JOHNSON, A, DOVLATOVA, N and AND HEPTINSTALL, H., 2008. Multiple electrode aggregometry and P2Y12 antagonists Thrombosis and Haemostasis. 99(6), 1127-1129
DOVLATOVA, N L, JAKUBOWSKI, J A, SUGIDACHI, A and HEPTINSTALL, S, 2008. The reversible P2Y antagonist cangrelor influences the ability of the active metabolites of clopidogrel and prasugrel to produce irreversible inhibition of platelet function. Journal of Thrombosis and Haemostasis: JTH. 6(7), 1153-9
WHITE, A., GLENN, J., FOX, S., JOHNSON, A., MYERS, B. and AND HEPTINSTALL, S., 2007. Reduced platelet aggregation to ADP and ATP in patients with leucocytosis is due to enhanced rates of adenine nucleotide metabolism mediated by the NTPDase CD39 Platelets. 18(1), 100 DOVLATOVA, N.L, JAKUBOWSKI, J.A, SUGIDACHI, A and AND HEPTINSTALL, S., 2007. Competition between reversible and irreversible P2Y12 antagonists and its influence on ADP-mediated platelet activation. Journal of Thrombosis and Haemostasis: JTH. 5(Supplement 2), P-S-340
HEPTINSTALL, S., MANOLOPOULOS, M., GLENN, J.R., FOX, S.C., MAY, J.A., DOVLATOVA, N., TANG, S-W., BAUER, N., HESSE, M., THOMAS, N.R. and RALEVIC, V., 2006. Acyl derivatives of coenzyme A inhibit ADP-induced platelet function via antagonism at P2Y1 and P2Y12 receptors. Purinergic Signalling. 2, 92-93
BURIACHKOVSKAIA, L I, POLIAKOVA, E O, ZORIN, A V, UCHITEL', I A, DOVLATOVA, N L, MASENKO, V P, SUMAROKOV, A B, KADUSHINA, E B, KUZENTSOVA, T A, POGORELOVA, T E and CHAZOV, E I, 2006. [Platelet activation and inflammation markers in patients with coronary heart disease and depression] Terapevticheskiĭ arkhiv. 78(10), 9-14